Myron Kaplan is Director at CorMedix Inc. (CRMD). They have made 18 open-market trades across 1 company since 2016, most recently 2026-01-26.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
18 open-market purchases totalling $1.1M since 2016, never a sale. Across 18 scored buys the stock is up 5.8% at ninety days, and 0.1 points ahead of the S&P over the same stretch.
18 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CRMD | 231,487 | $1.7M |
| KHK | 160,299 | — |
| Total | $1.7M |
Shares reported on the most recent Form 4, priced at the 2026-01-27 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 56% | 56% |
| Avg Move | +4.6% | +9.0% | +5.8% |
| Alpha | +3.9% | +8.1% | +0.1% |
| Scored | 18 | 18 | 18 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRMD | BUY | 2025-10-23 | 2025-10-27 | $11.02 | $276K | -7.5% | -17.2% | -33.4% |
| CRMD | BUY | 2023-05-18 | 2023-05-19 | $4.54 | $27K | -0.8% | +9.4% | -18.3% |
| CRMD | BUY | 2022-05-17 | 2022-05-18 | $3.78 | $19K | -9.7% | -21.4% | +19.2% |
| CRMD | BUY | 2021-11-16 | 2021-11-19 | $5.14 | $51K | -4.6% | -9.0% | -21.4% |
| CRMD | BUY | 2021-05-17 | 2021-05-19 | $6.03 | $90K | +5.5% | +11.1% | -11.1% |
| CRMD | BUY | 2020-09-02 | 2020-09-04 | $4.27 | $131K | +15.7% | +46.7% | +110.1% |
| CRMD | BUY | 2020-08-13 | 2020-08-17 | $4.08 | $61K | +2.2% | -0.4% | +25.9% |
| CRMD | BUY | 2020-05-15 | 2020-05-18 | $3.85 | $39K | +3.3% | +36.0% | +3.0% |
| CRMD | BUY | 2019-09-30 | 2019-10-01 | $6.81 | $34K | -16.0% | -10.0% | +10.6% |
| CRMD | BUY | 2019-08-16 | 2019-08-16 | $8.06 | $48K | -8.8% | -2.8% | -39.7% |
| CRMD | BUY | 2019-03-22 | 2019-03-22 | $1.65 | $33K | +21.6% | +2.7% | -7.8% |
| CRMD | BUY | 2018-12-14 | 2018-12-17 | $1.47 | $74K | -2.3% | +48.5% | +29.2% |
| CRMD | BUY | 2018-11-23 | 2018-11-27 | $1.30 | $65K | +30.5% | +2.3% | +47.7% |
| CRMD | BUY | 2017-12-12 | 2017-12-14 | $0.48 | $50K | -8.6% | -10.4% | -48.8% |
| CRMD | BUY | 2017-08-17 | 2017-08-21 | $0.40 | $32K | +29.9% | +5.6% | +35.2% |
| CRMD | BUY | 2017-08-14 | 2017-08-16 | $0.35 | $18K | +34.5% | +5.6% | +20.2% |
| CRMD | BUY | 2017-05-15 | 2017-05-17 | $0.49 | $15K | -13.8% | -8.5% | -21.3% |
| CRMD | BUY | 2016-08-19 | 2016-08-23 | $1.72 | $69K | +10.9% | +74.5% | +4.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.